The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
CYCLIZINE JUNO (Juno Pharmaceuticals Pty Ltd)
Product name
CYCLIZINE JUNO
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
163 (255 working days)
Active ingredients
cyclizine lactate
Registration type
New generic medicine
Indication
CYCLIZINE JUNO is indicated for the prevention of nausea and vomiting in the postoperative period